i-SENS Inc (KQ:099190) — Market Cap & Net Worth

$147.56 Million USD  · ₩217.73 Billion KRW  · Rank #17814

Market Cap & Net Worth: i-SENS Inc (099190)

i-SENS Inc (KQ:099190) has a market capitalization of $147.56 Million (₩217.73 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17814 globally and #749 in its home market, demonstrating a -7.85% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying i-SENS Inc's stock price ₩15850.00 by its total outstanding shares 13737200 (13.74 Million). Also see 099190 total asset value for a full breakdown of the balance sheet.

i-SENS Inc Market Cap History: 2015 to 2026

i-SENS Inc's market capitalization history from 2015 to 2026. Data shows change from $149.51 Million to $147.56 Million (-0.59% CAGR). Also see i-SENS Inc (099190) cash conversion ratio for how efficiently the company converts equity into cash flow.

Index Memberships

i-SENS Inc is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
Kosdaq Composite Index
KOSDAQ
$234.31 Billion 0.06% #271 of 1384
Kosdaq Composite Index
KQ11
$234.31 Billion 0.06% #271 of 1384

Weight: i-SENS Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

i-SENS Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how i-SENS Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of i-SENS Inc for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.00x

i-SENS Inc's market cap is 0.00 times its annual revenue

Industry average: 0.00x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $129.54 Million $132.47 Billion $17.56 Billion 0.00x 0.01x
2017 $111.91 Million $156.96 Billion $15.73 Billion 0.00x 0.01x
2018 $100.22 Million $173.00 Billion $22.62 Billion 0.00x 0.00x
2019 $115.39 Million $189.84 Billion $23.43 Billion 0.00x 0.00x
2020 $135.88 Million $203.71 Billion $26.84 Billion 0.00x 0.01x
2021 $138.43 Million $232.93 Billion $25.45 Billion 0.00x 0.01x
2022 $152.16 Million $264.84 Billion $16.14 Billion 0.00x 0.01x
2023 $266.25 Million $265.12 Billion $3.71 Billion 0.00x 0.07x
2024 $142.16 Million $291.14 Billion -$1.79 Billion 0.00x N/A
2025 $148.02 Million $315.44 Billion -$5.15 Billion 0.00x N/A

Competitor Companies of 099190 by Market Capitalization

Companies near i-SENS Inc in the global market cap rankings as of September 18, 2026. Review how tangible is i-SENS Inc's equity to assess the quality of the company's equity after excluding intangible assets.

Key companies related to i-SENS Inc by market ranking:

  • InBody Co.Ltd (KQ:041830): Ranked #12012 globally with a market cap of $530.86 Million USD ( ₩783.34 Billion KRW).
  • INFINITT Healthcare Co. Ltd (KQ:071200): Ranked #16265 globally with a market cap of $221.36 Million USD ( ₩326.65 Billion KRW).
  • Sewoon Medical Co. Ltd (KQ:100700): Ranked #20601 globally with a market cap of $71.58 Million USD ( ₩105.63 Billion KRW).
  • Meta Biomed Co. Ltd (KQ:059210): Ranked #21289 globally with a market cap of $60.26 Million USD ( ₩88.92 Billion KRW).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#12012 InBody Co.Ltd KQ:041830 $530.86 Million ₩58100.00
#16265 INFINITT Healthcare Co. Ltd KQ:071200 $221.36 Million ₩13400.00
#20601 Sewoon Medical Co. Ltd KQ:100700 $71.58 Million ₩2440.00
#21289 Meta Biomed Co. Ltd KQ:059210 $60.26 Million ₩3785.00

i-SENS Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, i-SENS Inc's market cap moved from $149.51 Million to $ 147.56 Million, with a yearly change of -0.59%.

Year Market Cap Change (%)
2026 ₩147.56 Million -0.31%
2025 ₩148.02 Million +4.13%
2024 ₩142.16 Million -46.61%
2023 ₩266.25 Million +74.98%
2022 ₩152.16 Million +9.92%
2021 ₩138.43 Million +1.88%
2020 ₩135.88 Million +17.76%
2019 ₩115.39 Million +15.14%
2018 ₩100.22 Million -10.45%
2017 ₩111.91 Million -13.61%
2016 ₩129.54 Million -13.36%
2015 ₩149.51 Million --

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of i-SENS Inc was reported to be:

Source Market Cap
Yahoo Finance $147.56 Million USD
MoneyControl $147.56 Million USD
MarketWatch $147.56 Million USD
marketcap.company $147.56 Million USD
Reuters $147.56 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About i-SENS Inc

KQ:099190 Korea Healthcare Equipment & Supplies
Market Cap
$147.56 Million
₩217.73 Billion KRW
Market Cap Rank
#17814 Global
#749 in Korea
Share Price
₩15850.00
Change (1 day)
-0.38%
52-Week Range
₩14690.00 - ₩27000.00
All Time High
₩38452.83
About

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more